THERE is an intense and active debate concerning the need for board certification among the three major societies that represent clinical pharmacology. In fact, a task force composed of members of the American College of Clinical Pharmacology (ACCP), the American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the Clinical Pharmacology Division of the American Society for Pharmacology and Experimental Therapeutics (ASPET) is now at work to resolve this problem. The need to address this problem has arisen because the American Board of Clinical Pharmacology was actually incorporated in August 1976 by a group of distinguished clinical pharmacologists. This board has the moral support of the ACCP but is independent of the three societies. The board has agreed to delay its first examination and confirmation to the American Board of Medical Specialists until the task force has completed its deliberations.
It is pertinent to restate here the reasoning, the pros